Polyomaviruses KI and WU in immunocompromised patients with respiratory disease

Thomas Mourez; Anne Bergeron; Patricia Ribaud; Catherine Scieux; Régis Peffault de Latour; Abdellatif Tazi; Gérard Socié; François Simon; Jérôme LeGoff

doi:10.3201/eid1501.080758

Polyomaviruses KI and WU in immunocompromised patients with respiratory disease

Emerg Infect Dis. 2009 Jan;15(1):107-9. doi: 10.3201/eid1501.080758.

Authors

Thomas Mourez¹, Anne Bergeron, Patricia Ribaud, Catherine Scieux, Régis Peffault de Latour, Abdellatif Tazi, Gérard Socié, François Simon, Jérôme LeGoff

Affiliation

¹ Laboratory of Microbiology, Saint Louis University Hospital, Paris.

Abstract

Polyomaviruses KI (KIPyV) and WU (WUPyV) were recently identified, mainly in respiratory specimens from children. Among 200 patients with respiratory disorders admitted to Saint Louis Hospital, Paris, France, KIPyV was detected in 8% and WUPyV in 1%. KIPyV was significantly more frequent among human stem cell transplant patients (17.8% vs. 5.1%; p = 0.01).

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Female
Hospitalization / statistics & numerical data
Humans
Immunocompromised Host
Male
Middle Aged
Paris / epidemiology
Polyomavirus / classification*
Polyomavirus / isolation & purification*
Polyomavirus Infections / epidemiology*
Polyomavirus Infections / virology
Prevalence
Respiratory Tract Infections / epidemiology*
Respiratory Tract Infections / virology
Stem Cell Transplantation / adverse effects*
Young Adult